We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$228B
AUM Growth
-$15.4B
Cap. Flow
-$1.28B
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.8%
Holding
11,885
New
1,174
Increased
4,828
Reduced
3,849
Closed
1,024

Sector Composition

Rank Sector Weight
1 Technology 10.88%
2 Financials 6.67%
3 Healthcare 6.52%
4 Consumer Discretionary 4.99%
5 Industrials 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYMCZ
10176
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$1K ﹤0.01%
18,066
-45,929
-72% -$3.38K
PMVC.WS
10177
DELISTED
PMV Consumer Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PMVC.WS
$1K ﹤0.01%
15,420
-6,850
-31% -$338
SANBW
10178
DELISTED
Sanaby Health Acquisition Corp. I Warrant
SANBW
$1K ﹤0.01%
10,470
REC
10179
DELISTED
Emles Real Estate Credit ETF
REC
$1K ﹤0.01%
47
FVT.WS
10180
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$1K ﹤0.01%
10,202
+9,682
+1,862% +$1.47K
HYT.RT
10181
DELISTED
BlackRock Corporate High Yield Fund, Inc. Rights (expiring October 13, 2022)
HYT.RT
$1K ﹤0.01%
+344,031
New +$1.96K
CALA
10182
DELISTED
Calithera Biosciences, Inc
CALA
$1K ﹤0.01%
321
-679
-68% -$2.32K
POTX
10183
DELISTED
Global X Cannabis ETF
POTX
$1K ﹤0.01%
50
-40
-44% -$673
NBRV
10184
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1K ﹤0.01%
381
-886
-70% -$3.73K
RSXJ
10185
DELISTED
VanEck Russia Small-Cap ETF
RSXJ
$1K ﹤0.01%
69
EMKR
10186
DELISTED
Emcore Corp
EMKR
$1K ﹤0.01%
62
-18,947
-100% -$506K
CPTNW
10187
DELISTED
Cepton, Inc. Warrant
CPTNW
$1K ﹤0.01%
3,469
NOVVU
10188
DELISTED
Nova Vision Acquisition Corp. Unit
NOVVU
$1K ﹤0.01%
56
LVOXU
10189
DELISTED
LiveVox Holding, Inc. Unit
LVOXU
$1K ﹤0.01%
260
JUN.WS
10190
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$1K ﹤0.01%
5,000
-18,923
-79% -$3.61K
PEI
10191
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$1K ﹤0.01%
386
MIMO.WS.C
10192
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS.C
$1K ﹤0.01%
101
+7
+7% +$140
FIEE
10193
FiEE Inc
FIEE
$25.5M
$1K ﹤0.01%
155
-708
-82% -$6.02K
AAA
10194
Alternative Access First Priority CLO Bond ETF
AAA
$44.8M
-4
Closed
ABEO icon
10195
Abeona Therapeutics
ABEO
$366M
-1,773
Closed -$9K
ACHV icon
10196
Achieve Life Sciences
ACHV
$659M
-1,077
Closed -$5K
ACIO icon
10197
Aptus Collared Investment Opportunity ETF
ACIO
$2.36B
-453
Closed -$13K
ACONW icon
10198
Aclarion Warrant
ACONW
$0 ﹤0.01%
+2,500
New +$648
ACR
10199
ACRES Commercial Realty
ACR
$124M
-2,759
Closed -$23K
ZNB
10200
Zeta Network Group
ZNB
$551K
0
-$15K

Similar funds

UBS Group's Q3 2022 Portfolio in Review

As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2022 filing shows 1,174 new, 4,828 increased, 3,849 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
  • UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
  • UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
  • UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
  • UBS Group opened 1,174 new positions and closed 1,024 in Q3 2022.
  • UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.